COVID-19 U07.1
Conditions
Interventions
Group 1: From all patient in COVID-test station will be taken a breath sample for analysis in IMS device additional to smear test from mouth or nose cavity, after receiving the patients consent.
Gr
Sponsors
Helios Klinikum Aue
Eligibility
Sex/Gender
All
Age
18 Years to 90 Years
Inclusion criteria
Inclusion criteria: Indikation gemäß Zielstellung - Verdacht auf COVID-19 - Patient/Proband kommt in Abstrichstelle - gesund bzw. frei von florider klinisch relevanter Infektion, aber mögliche Kontaktperson zu COVID-positiven Patienten (V.a. symptomlosen Träger) oder Einweisung mit Beschwerden indication due to aim o the study, suspicion of COVID-19 presentation in test unit healthy or free of signs of infection contact to COVID-19 cases or typical symptoms for Covid
Exclusion criteria
Exclusion criteria: mechanical closure of both nasal sides
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Primary target of the study is to find and demonstrate rproducible cluster of volatile markers in IMS-spectra of exhaled breath and biological samples which are sufficient hints of a virale or bacterial infection. | — |
Secondary
| Measure | Time frame |
|---|---|
| surely exclusion of clinical relevant infection or absence of infective disease, resp., using exhaled markers. | — |
Countries
Germany
Contacts
Public ContactThomas Junghans
Helios-Klinikum Aue
Outcome results
None listed